A small pharmaceutical company needed a strong evidence base to support its product launch, justify pricing, and gain regulatory and payer approvals. However, siloed efforts and unclear market positioning created challenges.
Challenges:
- Fragmented evidence generation led to inefficiencies.
- Unclear patient targeting made market positioning difficult.
- Regulatory and payer hurdles threatened approval and reimbursement.
Axtria's Solution:
- Systematic Literature Review to identify gaps
- Real-World Data Analysis to quantify disease burden
- Economic Modeling to demonstrate cost-effectiveness
The Impact:
By integrating insights gained from integrated evidence planning, the client strengthened its market positioning, secured a compelling economic argument for payers, and ensured a smoother path to regulatory approval. The iterative approach also created a foundation for future evidence generation, streamlining post-launch studies.
Result:
A well-supported product launch with a clear value proposition, optimized market access, and increased stakeholder confidence.
Download the complete case study to learn more.
Contact us at connect@axtria.com with any questions.
